Although the two screened NSCLC cell lines H460 and A549 have mutations in other genes such as KRAS and PIK3CA, the target we wanted to find should be uniformly effective for the genetic subgroup of wtTP53‐RTK NSCLC regardless of the statuses of other genes. Here, KRAS is linked to non-small cell lung carcinoma.